For those patients taking GLP-1 agonists for primary diabetes management, 43% (612/1430) of respondents indicated they did not require their patients to hold the medication prior to undergoing elective surgery, 16% (224/1430) required holding for less than 1 week, 15% (214/1430) deferred to the primary care physician or endocrinologist, and 12% (180/1430) required holding the medication for 1 to 2 weeks. The gene discussed is GCG; the disease is diabetes mellitus.